Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Κύριοι συγγραφείς: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
Μορφή: | Journal article |
Έκδοση: |
American Society for Clinical Investigation
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Diagnostic use of autoantibodies in myasthenia gravis.
ανά: Leite, M, κ.ά.
Έκδοση: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
ανά: Miriam L. Fichtner, κ.ά.
Έκδοση: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
ανά: Gomez, A, κ.ά.
Έκδοση: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
ανά: Miriam L Fichtner, κ.ά.
Έκδοση: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
ανά: Miriam L. Fichtner, κ.ά.
Έκδοση: (2022-01-01)